International Journal of Drug Policy

Article	Citations
Bridging the gap: An environmental scan of post-overdose program features and evaluation measures	230
Editorial Board	152
Editorial Board	85
Editorial Board	80
Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada	67
Publisher's Note	67
Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare	61
Social-spatial network structures among young urban and suburban persons who inject drugs in a large metropolitan area	58
Doing more with less: A proposal to advance cigarette packaging regulations in the United States	54
Enhancing equity-oriented care in psychedelic medicine: Utilizing the EQUIP framework	54
Increased solitary drug use during COVID-19: An unintended consequence of social distancing	53
Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers	51
The social-structural contexts of cannabis consumption and harm reduction among young Nigerian women	51
The introduction of fentanyl on the US–Mexico border: An ethnographic account triangulated with drug checking data from Tijuana	49
Quasi-experimental study on the impact of local smoke-free policies on smoking among Indonesian adults: Evidence from repeated national health surveys	48
Shifting awareness among electronic dance music party attendees that drugs may contain fentanyl or other adulterants	47
A content analysis of cannabis edibles package marketing in the United States	46
International property rights for Cannabis landraces and terroir products. The case of Moroccan Cannabis and hashish	45
Older age at smoking initiation predicts successful cessation in adults who smoke: A prospective study	45
Opioid prescribing restrictions and opioid use among the Louisiana Medicaid population	43
Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework	42
Incarceration history, antiretroviral therapy, and stigma: A cross-sectional study of people with HIV who inject drugs in St. Petersburg, Russia	42
A matter of craving–An archeology of relapse prevention in Swedish addiction treatment	41
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	41
Leveraging pooled medical examiner records to surveil complex and emerging patterns of polysubstance use in the United States	41

Editorial Board	40
‘Choice’ of social media platform or encrypted messaging app to buy and sell illegal drugs	40
Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts	40
Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States	40
How do patient, pharmacist and medication characteristics and prescription drug monitoring program alerts influence pharmacists' decisions to dispense opioids? A randomised controlled factorial experi	39
The impact of an easy access drug supply management policy law on the consumption and abuse of opioids in Catalonia: A population-based study	39
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis	39
Strategies for addressing needle debris: A scoping review of needle debris and discarded drug paraphernalia associated with substance use	38
Putting tendencies and trajectories to work: useful tools for engaging with accounts of change and recovery?	38
Applying a mutual capacity building model to inform peer provider programs in South Africa and the United States: A combined qualitative analysis	38
The hammer and the nail: The triple lock of methods, realities and institutional contexts in Australian research on nightlife violence	37
‘As for dignity and respect…. me bollix’: A human rights-based exploration of service user narratives in Irish methadone maintenance treatment	37
The harms of punishing substance use during pregnancy	36
Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia	36
Playing at the edges, navigating sexual boundaries, and narrating sexual distress; Practices and perspectives of sexuality and gender diverse people who use GHB	35
Societal costs of illegal drug use in Sweden	35
Your diagnosis will not protect you (and neither will academia): Reckoning with education and Dis-Ease	34
Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019–2020	34
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic	34
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids	34
Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans	34
Cannabis reduction among adolescents as spillover from successful tobacco control	32
Speed and smoking kill: A time-varying survival analysis linking methamphetamine use, cigarette smoking, and mortality in sexual minority men	32
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities	32
Psychosocial stress and methamphetamine use: A mixed-methods study of intersectional stigma and Aboriginal and Torres Strait Islander methamphetamine use	31
Cannabis industry lobbying in the Colorado state legislature in fiscal years 2010–2021	31
Transnational alcohol corporations in Nigeria as commercial determinants of health: Implications for policy	31
Likelihood of using a harm reduction vending machine among rural people who inject drugs in Appalachian Kentucky	31
Changes in arrests following decriminalization of low-level drug possession in Oregon and Washington	31
Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs	31
Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel	30
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study	30
The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial	30
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs	30
A readiness assessment for the prevention of alcohol-related harm in West Africa: A new methodological approach to inform practice and policy	29
Ethical justifications for safe supply interventions	29
Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis	29
‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram	28
Consent and violence amongst men in the context of sexualised drug use: A systematic scoping review	28
“What I should be doing is harm reduction, if I'm doing my job right”: Engagement with harm reduction principles among prosecutors enacting drug policy reform in the United States	28
Heavy burden of non-fatal overdose among people who inject drugs in San Francisco, 2022	28
Measuring drug policy evolution: A cross-country analysis	28
Suboptimal uptake and placement of a mandatory alcohol pregnancy warning label in Australia	28
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK	28
Comparing police use of drug detection dogs amongst injecting and non-injecting groups of people who regularly use drugs in Australia	28
High levels of all-cause mortality among people who inject drugs from 2018 to 2022	28
Do Australians use the prescription pathway when using nicotine vaping products to quit smoking?	27
How can communities influence alcohol licensing at a local level? Licensing officers’ perspectives of the barriers and facilitators to sustaining engagement in a volunteer-led alcohol harm reduction a	27
Trends in young people accessing English alcohol treatment services: 2014 to 2023	27
Spotting as a risk mitigation method: A qualitative study comparing organization-based and informal methods	27

Heavy episodic drinking and HIV disclosure by HIV treatment status among People with HIV in IeDEA Cameroon	27
Co-located Heroin Assisted Treatment within primary care: A preliminary analysis of the implications for healthcare access, cost, and treatment delivery in the UK	27
An examination of the role of changes in country-level leisure time internet use and computer gaming on adolescent drinking in 33 European countries	27
Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine	26
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”	26
Vaccination coverage among people who inject drugs: A systematic review	26
COVID-19 economic impact payments and opioid overdose deaths	26
Drug transactions and the dark web: Public perceptions of the locational setting of offenders and support for drug policy outcomes	26
Becoming a nitrous oxide user on social media: Learning to maximise pleasures and minimise harms	25
Editorial Board	25
Effectiveness and implementability of state-level naloxone access policies: Expert consensus from an online modified-Delphi process	25
Editorial Board	25
Haven't I waited long enough? The role of wait times and subjective impairment in cannabis-related driving behavior	25
Assessing HIV and overdose risks for people who use drugs exposed to compulsory drug abstinence programs (CDAP): A systematic review and meta-analysis	25
Editorial Board	25
Tackling the overdose crisis through unionization: A response to Rivera & Friedman (2024)	25
Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study	25
Drug use typology, demographic covariates, and associations with condomless anal sex: A latent class analysis among a U.S. national cohort of men who have sex with men	25
Public support for reinvesting resources from enforcing drug possession to health-promoting alternatives: A nationally representative poll of adults in the United States	24
Problematizing “patient stability” in opioid use disorder care: Flexible definitions, (in)flexible treatment	24
Municipal socioeconomic environment and recreational cannabis use in Mexico: Analysis of two nationally representative surveys	24
Drugs, guns, and violent crime in California	24
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study	23
Exploring trauma and wellbeing of people who use drugs after witnessing overdose: A qualitative study	23
2S/LGBTQ+ youth substance use and pathways to homelessness: A photovoice study	23
Exploring the need for overdose prevention centers in England: A qualitative community-based participatory study on the perspectives of people who use drugs in public and semi-public environments	23
Standard THC units: A tool to benchmark cannabis-related driving risks	23
Minimum legal age laws and perceived access to cigarettes, e-cigarettes, and other substances among youth in Canada, England, and the United States: 2017-2021	23
The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study	23
Editorial Board	23
The benefits and challenges of virtual SMART recovery mutual-help groups: Participant and facilitator perspectives	22
Cannabis legalization and changes in cannabis and tobacco/nicotine use and co-use in a national cohort of U.S. adults during 2017–2021	22
Naloxone cascade of care among people who regularly inject drugs in Australia, 2020–2022	22
Countering the institutionalization of harm reduction through critical pragmatism	22
Interconnected influence: Unraveling purdue pharmaceutical's role in the global response to the opioid crisis	22
Slamsex as slow edgework: Sexualized drug use and harm reduction in post-AIDS Taiwan	22
Social and structural determinants of health associated with police violence victimization: A latent class analysis of female sex workers who use drugs in Kazakhstan	22
The success rate of online illicit drug transactions during a global pandemic	21
Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement	21
The impact of alcohol minimum unit pricing on people with experience of homelessness: Qualitative study	21
Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes	21
Access and care for people with opioid use disorder in U.S. skilled nursing facilities: A policy commentary	21
Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people	21
The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use	20
Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis	20
Psychedelic discourses: A qualitative study of discussions in a Danish online forum	20
“Harm per litre” as a concept and a measure in studying determinants of relations between alcohol consumption and harm	20
Recreational cannabis excise taxation in the USA: Constructing a comparable tax measure for empirical analysis	20
Editorial Board	20
The intersection of substance use stigma and anti-Black racial stigma: A scoping review	20
‘Keeping a lid on it’: Exploring ‘problematisations’ of prescribed medication in prisons in the UK	20
We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers	20
Characterizing changes in drug use behaviour following supply shortages of 5-MeO-DIPT, alkyl nitrites and new psychoactive substances among men living with HIV in Japan	19
The importance of PEOPLE who use drugs within drug policy reform debates: Findings from the UK Drug Policy Voices online survey	19
Exploring how an e-cigarette intervention influenced tobacco smoking behaviour in people accessing homelessness services: Findings from the SCeTCH trial process evaluation	19
Decline in youth drinking in high-income settings: Implications for public health in low-income countries	19
Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison	19
Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada	19
Editorial Board	19
Current regulations in context: Scraping Australia's online nitrous oxide market	19
Post-retirement enlightenment syndrome: Worthy of investigation	19
A pilot implementation study to scale-up methadone in incarcerated persons with opioid use disorder and retain them on treatment after release in Moldova	19
The association between social capital and drug overdose mortality in the United States	18
The impacts of COVID-19 on structural inequities faced by people living with HIV who inject drugs: A qualitative study in St. Petersburg, Russia	18
Beverage-specific consumption trends: A cross-country, cross-sectional comparison	18
Transitions to legal cannabis markets: Legal market capture of cannabis expenditures in Canada following federal cannabis legalization	18
Through the wine glass: How biographical midlife transitions and women's affective interpretations interact with alcohol consumption	18
Examining the association between trenbolone, psychological distress, and aggression among males who use anabolic-androgenic steroids	18
“It’s not just the hit itself”: the social practice of injecting drug use among gay and bisexual men in Australia	18
Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit	18
The Baltic and Nordic responses to the first Taliban poppy ban: Implications for Europe & synthetic opioids today	18
Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis	18
Beyond the smoke: Historical analysis of the revenue implications of state cigarette tax policies, 1989 to 2019	18
Synergistic effects of exposure to multiple types of violence on non-fatal drug overdose among women who inject drugs in Indonesia	18
Patients prefer free drug disposal options delivered by pharmacists at the point of care: Results of a decision tree analysis of a national factorial vignette panel survey	18
Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19	18
Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011	17
Substances from unregulated drug markets – A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)	17
Recovery as a minor practice	17
An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study	17

Editorial - Supporting the best quality science and the rights of people who use drugs regardless of global policy changes: Perspectives from the co-Editors in Chief of the International Journal of Dr	17
A call for compassionate opioid overdose response	17
Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014–2020	17
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial	17
Digital localisation in an illicit market space: interactional creation of a psychedelic assemblage in a darknet community of exchange	17
Corrigendum to ‘Substances from unregulated drug markets – A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)’ [Volume 114, April	17
Holding ‘new recovery’ together: Organising relations and forms of coordination in professional sociomaterial practices of addiction recovery	17
Using a “Big Events” framework to understand emergency department use among women experiencing homelessness or housing instability in San Francisco during the COVID-19 pandemic	17
Facilitating access to direct-acting antivirals in a community-based point-of-diagnosis model for hepatitis C treatment: The role of the pharmacy team in the no one waits (NOW) study	16
Decrease in provider stigma is associated with improved quality health indicators among individuals receiving methadone in primary care centers in Ukraine	16
System dynamics modeling to inform implementation of evidence-based prevention of opioid overdose and fatality: A state-level model from the New York HEALing Communities Study	16
Voices represented and voices silenced: Represented voices in the media coverage of the implementation of a supervised injecting facility	16
Drug treatment and support service utilization amidst the COVID-19 pandemic among people who inject drugs in Baltimore, Maryland: An interrupted time-series analysis, 2015–2022	16
Corrigendum to “Sociological investigations of human enhancement drugs: The case of microdosing psychedelics” [International Journal of Drug Policy 95 (2021) 103099]	16
“It should be hard to be a drug abuser” An evaluation of the criminalization of drug use in Sweden	15
Disentangling opioids-related overdose syndemics: a scoping review	15
Changing Trends in Nonmedical Gabapentin Use Among a Cohort of Rural Appalachian People Who Use Drugs: A Longitudinal Study Over the Time Period of Scheduling Changes in Kentucky	15
Defining a public health approach to substance use: Perspectives from professionals and practitioners across Canada	15
The role of gifts in building influence with politicians: Thematic analysis of interviews with current and former parliamentarians	15
Trends in cannabis use among U.S. adults amid the COVID-19 pandemic	15
Radical hospitality: Innovative programming to build community and meet the needs of people who use drugs at a government-sanctioned overdose prevention site in San Francisco, California	15
Drug policy goals in a changing landscape: Perspectives of practitioners in Japan	15
Public calls for service to the police: Trends before and during drug possession decriminalization in Oregon	15
Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops	15
“I've lost my children to vaping”: A frame analysis of the Australian media's construction of the “Youth vaping crisis”	15
Unpacking the differing understandings of “alcohol industry” in public health research	15
Analysis of gaps in alcohol policies in Brazil using the Pan American Health Organization's Alcohol Policy Scoring	15
Community-administered naloxone for overdose reversal: The role of sex worker-led programming and occupational violence in a community-based cohort (2018–2024)	15
“There’s a lot of stereotypes going on”: A cross-national qualitative analysis of the place of gender in declining youth drinking	15
Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study	14
Volatile substances are an amorphous category, making it hard to build a comprehensive body of research	14
Association between U.S. state prenatal drug use laws and child welfare reporting in Alabama, Maryland and Utah	14
Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality	14
Towards equity for people who inject drugs in HIV prevention drug trials	14
Not just fentanyl: Understanding the complexities of the unregulated opioid supply through results from a drug checking service in British Columbia, Canada	14
Socio-ecological and pharmacy-level factors associated with buprenorphine stocking at pharmacies in New York City	14
The economic factors that determine smoking abstinence: a survival and mediation analysis	14
Can alcohol policy prevent harms to women and children from men's alcohol consumption? An overview of existing literature and suggested ways forward	14
From Anti-doping-I to Anti-doping-II: Toward a paradigm shift for doping prevention in sport	14
A concept mapping study of service user design of safer supply as an alternative to the illicit drug market	14
Out of pocket expenses: effect of fee-waivers on opioid prescribing and dispensing	14
‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States	14
Drug induced homicide laws may worsen opioid related harms: An example from rural North Carolina	14
‘I just drink to feel abnormal for some time’: Reconfiguring heavy drinking and intoxication as pleasurable	14
‘Some days I am a lunatic that thinks I can moderate’: Amalgamating recovery and neo-liberal discourses within accounts of non-drinking among women active in the ‘positive sobriety’ community on Insta	14
Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas	14
Editorial Board	14
Programmatic alcohol advertising, social media and public health: Algorithms, automated challenges to regulation, and the failure of public oversight	14
The effectiveness of smoking cessation interventions in rural and remote populations: Systematic review and meta-analyses	14
“Apparently, you can only be treated once”: A qualitative study exploring perceptions of hepatitis C and access to treatment among people who inject drugs visiting a needle and syringe program	13
Creativity, care and ‘messy’ drug use: A collective history of the early days of peer-led needle exchange in Dunedin, New Zealand	13
Safer supply programs: Discussions on medication diversion, sharing, and selling	13
Addressing the complex substance use and mental health needs of people leaving prison: Insights from developing a national inventory of services in Canada	13
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Ca	13
Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome Study	13
Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitioners	13
Using synthetic controls to estimate the population-level effects of Ontario's recently implemented overdose prevention sites and consumption and treatment services	13
Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review	13
Factors associated with attending “open bar” parties amongst early adolescents	13
Editorial Board	13
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis	13
Multilevel determinants of cannabis prices in legal markets: Evidence from products sold in nearly 4000 cannabis dispensaries in the United States	13
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020	13
Adherence to antiretroviral therapy among HIV positive men who inject drugs in Pakistan	13
Understanding the longitudinal relationship between substance use and violent victimization among street-based women who exchange sex in Baltimore, Maryland	13
Alcohol policy changes during the first three-months of the COVID-19 pandemic: Development and application of a classification scheme	13
Sex-specific trends in patterns of tobacco and nicotine use among young people in Denmark from 2020 to 2023: A multigroup latent class analysis	13
The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: a Survey Based Experiment	12
Are dietary supplement users more likely to dope than non-users?: A systematic review and meta-analysis	12
Exploring multiple drug use by integrating mobile health and qualitative mapping methods - An individual case study	12
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study	12
A scoping review of qualitative research on barriers and facilitators to the use of supervised consumption services	12
Effective package warning label systems for communicating relative risks of cigarettes, heated tobacco products, and e-cigarettes: An experimental study with Korean adults	12
Cannabis industry campaign expenditures in Colorado, 2005-2021	12
Stimulant-involved overdose deaths: Constructing dynamic hypotheses	12
Implementation of a multi-component alcohol policy in Ireland: A qualitative study exploring barriers and facilitators to implementation	12
‘What makes up wine o'clock? Understanding social practices involved in alcohol use among women aged 40–65 years in Australia	12
Psychomodulatory substances: New legislative framework for control of psychoactive substances in Czechia	12
Editorial Board	12
Political constructions of people who use drugs in the Philippines: A qualitative content analysis	12
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis	12
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs	12
Public transport access to drug treatment before and during COVID-19: Implications for the opioid epidemic	12
Like birds of a feather? A multi-case study on the connections between cannabis, tobacco, alcohol and pharmaceutical companies in legalized cannabis markets	12
‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue	12
Where to next? An exploration of ‘night-out’ location progression and propensity to experience violence in night -time entertainment precincts	12
Unlocking deflection: The role of supervisor support in police officer willingness to refer people who inject drugs to harm reduction services	12
Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk	12
Is the affordability of cigarettes associated with the prevalence of smoking and quitting at the regional level in Russia?	12
Are recreational cannabis laws associated with declining medical cannabis program enrollment in the U.S.? An analysis of cardholder enrollment and demographic characteristics from 2013 to 2020	12
Pilot model of hepatitis C virus micro-elimination in high-risk populations in Hong Kong: Barriers and facilitators	11
Editorial Board	11
Response to “Operational and contextual barriers to accessing supervised consumption services in two Canadian cities”	11
Recruiting opioid treatment program administrators for a national survey: Outcomes and lessons learned	11
Association of sex work and social-structural factors with non-fatal overdose among women who use drugs in Vancouver, Canada	11